BioBoard
•  Heantos Shows Promise in Aiding Drug Withdrawal
•  Agilent Products Help Cancer Scientists Study Chromosomal Changes
•  Paradigm Therapeutics Ltd Acquires Amedis Pharmaceuticals Ltd

Special Report
•  Private Stem Cells Initiatives
•  Placenta-derived Multipotent Cells
•  Somatic Cell Nuclear Transfer
•  Diabetes Research Sweetened by Stem Cell License
•  Xeno-free Stem Cell Research
•  Asia's Emerging Eminence in Stem Cell Field
•  UK Determined to Maintain Lead - Call for Stem Cell Fund
•  Chinese Scientists Achieve Stem Cell Breakthrough
•  Stem Cell Lines in Disarray: Shakeup for Global Research

Industry Watch
•  Peptech Plans for Substantial Growth
•  Norwood Abbey to Begin Bone Marrow Trials
•  BBIL Vaccines Enter World Market
•  Lupin Strikes Deal with Cornerstone BioPharma to Market Suprax in US
•  Dr Reddy's Facing Up to Sobering Financial Perspective
•  Ranbaxy's Revital Faces Strong Competition with Entry of Swiss-Produced Drug Pharmaton
•  Shantha Biotech Launches Vaccine Delivery Device
•  Melsmon Ordered to Stop Output of Drug Made with Placenta
•  CyGenics Secures Exclusive Licence on Enhanced T Cell Production Technologies
•  An Association to Foster Bioscience in Singapore
•  Seeing Through the Brain
•  Herbal Drug for Hepatitis B Unveiled

Products/Services Highlights
•  Leading Australian Transplant Hospital Begins CE Mark Trial Implants

Research Findings
•  India Launched Its First Human Clinical Trial of AIDS Vaccine
•  Singapore Scientists Develop Anticancer Synthetic Protein

Agriculture
•  Rice Biotech Park Planned
•  Japan Approves Roundup Ready Herbicide-Resistant Alfalfa

General News
•  Consumer Group Opposes the Removing of US Beef Ban
•  Taiwan Government to Formulate New Biotech Strategies

Conference Calendar